Pfizer Jumps On Mixed, But 'Marginally Encouraging,' Guidance - Investor's Business Daily
- Pfizer Jumps On Mixed, But 'Marginally Encouraging,' Guidance Investor's Business Daily
- Pfizer Shares Jump 4% on Positive 2025 Outlook Despite $1B Impact Yahoo Finance
- Pfizer Sees 2025 Revenue in Line With Wall Street Views The Wall Street Journal
- Pfizer’s In-Line Guidance Offers Relief to Weary Investors Bloomberg